School of Biomedical Sciences, The University of Queensland, St Lucia, Queensland 4072, Australia.
Clin Sci (Lond). 2013 Aug;125(4):151-66. doi: 10.1042/CS20130011.
Heart development involves the precise orchestration of gene expression during cardiac differentiation and morphogenesis by evolutionarily conserved regulatory networks. miRNAs (microRNAs) play important roles in the post-transcriptional regulation of gene expression, and recent studies have established critical functions for these tiny RNAs in almost every facet of cardiac development and disease. The realization that miRNAs are amenable to therapeutic manipulation has also generated considerable interest in the potential of miRNA-based drugs for the treatment of a number of human diseases, including cardiovascular disease. In the present review, I discuss well-established and emerging roles of miRNAs in cardiac development, their relevance to congenital heart disease and unresolved questions in the field for future investigation, as well as emerging therapeutic possibilities for cardiac regeneration.
心脏发育涉及到在心脏分化和形态发生过程中,通过进化上保守的调控网络,对基因表达的精确调控。miRNAs(microRNAs)在基因表达的转录后调控中发挥重要作用,最近的研究已经确定了这些微小 RNA 在心脏发育和疾病的几乎各个方面的关键功能。miRNAs 可进行治疗性操作的认识,也为 miRNA 为基础的药物治疗多种人类疾病,包括心血管疾病的潜力,产生了相当大的兴趣。在本综述中,我讨论了 miRNAs 在心脏发育中的既定和新兴作用,它们与先天性心脏病的相关性以及该领域未解决的问题,以及心脏再生的新兴治疗可能性。